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to June 2013. Surgical outcomes were compared to those in 72 patients who underwent primary LP carried out by the same surgeons during the same study period.
RESULTS: The study group consisted of 14 men and 18 women with the mean age of 29AE 6 years. Mean operative time was 186AE 57 and 123AE 22 minutes in the secondary and primary LP groups, respectively. Mean hospital stay was 4.7 AE 2.3 and 4.3 AE 2.1 days in the two groups, respectively. Mean follow-up was 36 AE 11.2 months (range 24-72 months). The overall success rate for secondary LP was 90.6% compared to 94.4% in the primary LP group. There was no conversion to open surgery in both groups. Intraoperative and postoperative complications in secondary and primary LP were 9.4 and 12.5% versus 0 and 5.6% in both groups, respectively. CONCLUSIONS: LP is a safe and viable treatment option for secondary uretreopelvic junction obstruction with a success rate similar to that of primary repair but with longer operative time and higher complication rate. A good experience in laparoscopic reconstructive procedures is a prerequisite for optimal results. METHODS: A retrospective review was performed on all laparoscopic and robotic colorectal procedures at our institution between March 2011 and October 2016 where LUS were requested. Illuminated single lumen ureteral stents were placed and removed at the end of each procedure. Technical challenges with LUS placement and postoperative complications such as ureteral injury, hematuria and acute kidney injury (AKI) were evaluated. Statistical analysis was performed using SPSS v24.
RESULTS: LUS were placed during 120 laparoscopic or robotic-assisted bowel resections. Technical challenges were encountered in 15% of cases (n¼18), requiring dilatation of the urethra (n¼4) or ureter(n¼5), or placement of a non-illuminated stent (n¼8). Mean operative time for complicated vs uncomplicated LUS placement was 26.4 minutes (STD¼14.69) and 14.2 minutes (STD¼9.35) respectively (p<0.001). Estimated cost of complicated vs uncomplicated stent placement was $1472.33 (STD¼555.13) and $954.15 (STD¼265.58) respectively (p¼0.001). Estimated cost of bilateral vs unilateral LUS placement was $1209.90 (STD¼321.65) and $865.34 (STD¼378.01) respectively (p<0.001).Postoperative AKI was encountered in 9% of cases (n¼11). Of these, 72% (n¼8) received bilateral LUS, 18% (n¼2) received unilateral LUS, and 9% (n¼1) received an open-ended ureteral stent due to inability to place a LUS (p¼0.095). In total, 52 cases received bilateral LUS and 15% of these (n¼8) developed postoperative AKI. All AKI episodes were self-limited except in one patient who received bilateral LUS and developed postoperative oliguria, worsening creatinine, and mild hydronephrosis, requiring bilateral indwelling ureteral stent placement. 3% of patients (n¼4) developed postoperative hematuria that resolved without intervention. There was one ureteral injury despite bilateral LUS, which was identified intraoperatively and repaired robotically via ureteroureterostomy.
CONCLUSIONS: We found that complications associated with LUS placement are rare and mostly self-limited. While illuminated stents may improve intraoperative identification of the ureters, further investigation is needed to determine their effectiveness in the prevention of ureteral injury. METHODS: A retrospective analysis was performed in patients undergoing upper and lower UR for iatrogenic injury, complications of cancer surgery, and radiation, or retroperitoneal fibrosis. Distinction between upper and lower US was above and bellow the iliac vessels, respectively. Success was defined as ureteral patency on CTIVP, Mag-3 studies, symptoms resolution, and stabilization in renal function. A descriptive and a linear regression analysis were conducted to evaluate variables associated with recurrent stricture.
RESULTS: A total of 128 patients were included of which 18 underwent bilateral UR. Iatrogenic injury following pelvic surgery was the most common etiology of US, followed by radiation (26.3%) and idiopathic retroperitoneal fibrosis. There was no significant difference between groups for age (p¼0.23), gender (p¼0.36), length of stricture (p¼0.14), prior radiation exposure (p¼0.52) and estimated glomerular filtration rate (p¼ 0.10). Time to surgery, number of prior attempts at reconstruction and number of patients diverted prior to final reconstruction were significantly higher for patient with upper US (p value ¼ 0.02, 0.01 and 0.004, respectively). A total of 51% (74/ 146) of strictures treated were in the upper ureter and required complex reconstruction procedures. Median hospital stay was 7 days (range 1-56) and length of follow-up was 120 days (32 e 2824). Short-term complications developed in 52 (34.4%). With respect to lower UR (n¼72), the procedures performed were reimplant (33/72), VPH (22/72), ureterolysis (9/72), ileal ureter (IU -5/72), transureteroureterostomy (TUU -2/72) and ureteroureterostomy (UU -1/72). Success rates were 100%, 100%, 100%, 80%, 50% and 100%, respectively. With respect to upper UR (n¼74), the procedures performed were IU (42/74), ureterolysis (12/74), UU (8/74), vertical flap pyeloplasty (5/74), VPH (4/74), Boari flap (2/74), and TUU (1/74). Success rates were 95%, 83.3%, 100%, 80%, 50%, 50%, 0%, respectively. The overall success rate was 88%. Boari Flap, TUU and radiation exposure were associated with inferior outcomes after UR, with p values of 0.03, 0.006 and 0.01, respectively. CONCLUSIONS: Upper US required more complex procedures, associated with higher incidence of complications and a lower success rate when compared to lower US. Excellent anatomical and function outcomes are expected after the treatment of both upper and lower ureteral strictures. Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e305
